Epidermis is composed mainly of keratinocytes and is the major barrier of human body. The development and maintenance of normal epithelial structures and functions require the transcription factor p63. The p63 gene encodes proteins with structures similar to that of p53, including an N-terminal transactivation (TA) domain, a DNA-binding domain and a carboxy-oligomerization domain. TAp63 and ΔNp63 (p63 isoforms without TA domain) regulate a wide range of target genes that are important for embryonal development and epithelial integrity. Mutations of p63 gene cause epidermal abnormalities characterized by ectodermal dysplasia. Recent reports have indicated that p63 plays important role in tumorigenesis as well. However, the relative importance of TAp63 and ΔNp63 in epidermal development and tumorigenesis remains mostly unclear and awaits further investigation. In this review, we summarize the current knowledge on the structure and function of p63 and its isoforms. (Biomed J 2012;35:457-63) 
T he human p63 gene is located on chromo some 3q27 and composed of 15 exons spanning more than 250 kb. [1] The p63 gene contains two promot ers, alterna tive promoter usage and C-terminal splicing generate two groups of three isoforms named TAp63, b, γ and ΔNp63, b, γ [ Figure 1 (A)]. [2] The TAp63 isoforms contain the N-terminal transactivation (TA) domain and are capable of transactivating target genes. In contrast, the ΔNp63 isoforms lack the TA domain and are believed to act as negative regulators of the TAp63 function. [3] Both p63 and p53 genes encode proteins with similar functional domains, high degrees of sequence homologies, and are suggested to regulate common target genes [ Figure 1 (B)]. The p63α protein contains an additional sterile alpha motif (SAM) domain that is not found in p53, it is a proteinprotein interaction domain believed to be involved in the developmental processes. [4, 5] Because of the sequential similarities, TAp63 proteins are able to bind and transactivate many p53 target genes; [6] however, many studies indicated that TAp63 proteins can bind DNA through responsive elements related to p63 but not p53. [7] [8] [9] Because of the lack of TA domain, ΔNp63 was reported to block p53 or TAp63-mediated transactivation. [2] Moreover, ΔNp63 has subsequently been demonstrated to transactivate their own target genes rather than just a dominant negative regulator over TAp63 and p53. [10] [11] [12] The functions of distinct p63 isoforms have not been defined, both TAp63 and ΔNp63 mRNA were found to be present in mouse embryos and mature epithelia; however, the ΔNp63 protein level is much higher than TAp63 in most of the postdevelopmental tissues. [13, 14] In contrast, TAp63 is more strongly expressed in oocytes than ΔNp63, implying their different regulatory roles during development. [15, 16] p63 in embryonic epithelia p63 is expressed in the ectodermal surfaces of the limb buds, branchial arches and epidermal appendages in mouse embryo. [17] The function of p63 in epithelial development was first observed in p63-/-mice. p63-null mice were born alive but soon died of dehydration due to severe defects in the development of stratified epithelial barrier. [17, 18] Reintroduction of TAp63α in p63-/-mice showed only limited areas of epithelialization, whereas reintroduction of ΔNp63α showed better epithelialization, although still with limited epidermal basal layer formation. [19] Other major defects in p63-/-mice include truncated limbs and deformed craniofacial structures. [17, 18] The skin of p63-negative mice was not stratified, did not express differentiation markers and was arrested in its early developmental stage. [18] p63-negative mice were also found to lack the structures associated with epidermal-mesenchymal interactions during embryonic development, [18, 20] the epidermis were found to undergo nonregenerative differentiation, leading to the absence of all squamous epithelia and their derivatives, including mammary, lacrymal and salivary glands. [17] Later study showed that TAp63 was the first p63 isoforms expressed during mouse embryogenesis and was required for the initiation of epithelial stratification program and the inhibition of terminal differentiation. [21] In the contrary, ΔNp63 counteracted TAp63 function and promoted the maturation of embryonic epidermis. [21] In accordance with the above observations, disruption of ΔNp63 expression in zebrafish was found to result in the failure of epidermal morphogenesis and fin truncations. [22, 23] At the molecular level, ΔNp63 has been shown to regulate genes characteristic of the epidermal basal layer (K14) and TAp63 regulate genes characteristic of the superbasal layer's (Ets-1, K1, transglutaminases, involucrin). [19] In addition, ΔNp63 was suggested to integrate multiple signaling pathways required for the tooth and hair placodes formation by regulating Bmp-7, Fgfr2b, jag1, Notch1 expression. In turn, ΔNp63 expression was promoted by BMP2, BMP7 and FGF10. [24] In addition, p63 was also suggested to regulate the cell proliferation and differentiation of tooth germ epithelial cells. [25] Taken together, p63 appeared to be required for the maintenance of certain progenitor cell populations that are necessary for epithelial turn over and development, while 
p63 in adult epithelia
The corneal epithelium exhibits high level of cellular turn over under normal physiology and in wound healing. Corneal epithelial cells are driven from limbal epithelial stem cells, a special population of progenitor cells located in the basal layer of the corneoscleral limbus. In the corneolimbal surface, p63 was found to be expressed in the basal layer of the limbal epithelium but not in the cornea, [26, 27] suggesting a role of p63 in limbal stem cell maintenance and differentiation. The successful reconstruction of limbal deficient eyes with cultured limbal epithelial cells, [28] and the observation that a higher percentage of the p63-positive cell in the prosthesis led to a higher successful reconstruction rate strongly supported the above notion. [29] However, the expression patterns of p63 and other keratinocyte stem cell markers in rat cornea appeared to be differed from that of human and rabbit. In an earlier report, we found that the expression of p63 in rat cornea was altered with age. In the neonates, p63-positive cells were present in limbus, peripheral cornea and central cornea. In 1-month-old rats, they were present in central and peripheral cornea, but not in limbus, and in adult rats (6 month and older), the p63-positive cells were present only in the peripheral cornea. [30, 31] In rabbits, the expression pattern was obviously different, we found that the expression of TAp63 was expressed at the highest level in limbus, decreased in peripheral cornea by approximately 10-fold and was undetectable in the central cornea. Rather similarly, ΔNp63 was also expressed at the highest level in limbus, decreased by approximately 35% in peripheral cornea, and was undetectable in the central cornea. [32] The expression of these proteins exhibited clear effect in the limbal explant cultures, we showed that knockdown of TAp63 expression inhibited the proliferation but promoted the differentiation of cultured rabbit limbal keratinocytes. Knockdown of ΔNp63 expression also inhibited cell proliferation, however, exerted no obvious effect on cell differentiation. [32] Recently, we showed KGF is a potent growth stimulator for the epithelial outgrowth from limbal explants and the stimulation was dependent on p38-mediated ΔNp63α expression. [33] Stimulation of limbal epithelial outgrowth by KGF was significantly reduced by knockdown of ΔNp63α, strongly supported a role of ΔNp63α in the regulation of limbal epithelial cell proliferation and differentiation.
Taken together, TAp63 and ΔNp63 appeared to play distinct roles in regulating proliferation and differentiation of the limbal epithelial cells, and were probably required for the maintenance of the limbal and corneal epithelial integrity.
p63 as a transcription factor
The functions of distinct p63 isoforms have not been clearly elucidated. Although both TAp63 and ΔNp63 transcripts were found in mouse embryo and mature epithelia, the ΔNp63 protein level was shown to be much higher than TAp63 in most of the postdevelopmental tissues. [13, 14] In contrast, TAp63 was shown to be strongly expressed in oocytes. [15, 16] Due to isoform diversity, intensive studies have focused on examining the signaling pathways regulated by p63 and on genes that may be activated or repressed. Since p63 and p53 proteins are structurally highly homologous with very similar DNA-binding domains. [2, 34] the initial studies were focused on whether p63 regulates p53 target genes. In this regard, TAp63 has been suggested to transactivate p53-responsive genes, whereas ΔNp63 acts in a dominant negative manner. [2] Recently, a transcriptional inhibitory domain (TID) located between the SAM domain and the C-terminus has been identified in p63α and was shown to mediate the repressive effects of p63α variants. [35] The C-terminus of TAp63α proteins is proposed to interact with the TA domain to prevent its binding to coactivator proteins. [35] This was supported by the report shown that TAp63γ stimulates the transcription of p53 responsive gene, whereas TAp63α showed little transactivation activity. In addition, ΔNp63α was reported to repress the transcription activity of p53 and TAp63, but ΔNp63γ could only repress the transcription activity of p53. [2] Another study demonstrated that TAp63 binds directly to the p53-responsive genes, including mdm2, bax, PERP and NOXA, suggesting possible functional overlaps of TAp63 and p53 in regulating the genome stability and apoptotic functions of the p53. [36, 37] Transient transfection of cells with TAp63 variants has been reported to induce both cell cycle arrest and apoptosis. [2, 38, 39] These studies showed that TAp63γ variant exhibited the greatest transactivation activity, in contrast, TAp63α exhibit less or no activity. A similar study confirmed that ΔNp63 variants exhibited opposite effects on cell cycle regulation and apoptosis compared to that generated by TAp63 variants. [2] Loss of TAp63 has been shown to result in failure of p53 expressing cells to undergo apoptosis in response to DNA damage, [36] suggesting the involvement of p63 in regulating cell fate under genotoxicity. In contrast, p53 knockout mice exhibited no developmental epithelial disorders, suggests a distinctive regulatory function from that of p63. Further studies to delineate the exact roles of six p63 variants in keratinocyte differentiation and proliferation is still yet to come. [40] ΔNp63α has also been reported to act as a transcriptional repressor required for ventral specification in the ectoderm of gastrulating embryos. [22] It could also repressed the gene transcription through fusing with the yeast transcription factor Gal4, [41] suggesting a unique regulatory mechanism independent of its promoter binding activity.
Regulation of p63 stability and activity
The expression of TAp63 in normal tissue is highly restricted and has rarely been reported. Recently, TATAbinding protein-like protein (TLP), a protein regulates stressmediated cell cycle checkpoint and apoptotic pathways, was shown to upregulate the transcriptional activity of TAp63. [42] However, the mechanism underlying such regulation awaits further study. The TAp63 protein stability was reported to be regulated by its transactivation domain (TA), at the amino terminal residues 50 to 69. [43] Moreover, WWP1 E3 ubiquitin ligase was reported to bind, ubiquitinate, and destruct both ΔNp63α and TAp63α through the proteasome pathway. [44] Other studies showed that Plk1 was able to bind to TAp63 at Ser-52 of the TA domain leading to its phosphorylation, which in turn led to decreased TAp63 protein stability and TAp63-induced cell death. [44, 45] EGFR pathway has been reported to regulate the expression of ΔNp63α. [46] ΔNp63α expression was also regulated by the PI3K pathway and plays a critical role in the survival and proliferative capacity of the squamous epithelia. [47] The PI3K pathway activity was reported to be implicated in a number of human diseases including diabetes and cancer. [48, 49] Our previous study showed that in NPC076 cell, ΔNp63 imposes a dual-regulatory effect on its own promoter activity. [50] We showed that ΔNp63 transcriptional activity is downregulated when ΔNp63 is present in low levels. In contrast, it was upregulated when ΔNp63 is expressed at higher levels. The autoregulation of ΔNp63 gene transcription was mediated through activation of STAT3 and its subsequent binding to the STAT3 response element in its own promoter. [51] We also showed that STAT3 enhances the proliferation of limbal keratinocytes through a ΔNp63-dependent mechanism. [52] Moreover, we also found that inhibition of glycogen synthase kinase-3beta (GSK-3beta) by lithium chloride (LiCl) leads to increased ΔNp63 promoter activity and protein expression in HEK 293T cells. [53] We showed that GSK-3beta inhibitor stimulates ΔNp63 promoter activity through beta-catenin responsive element. Beta-catenin interacted with Lef-1 to regulate ΔNp63 promoter activity and protein expression. [53] In vivo studies showed that ΔNp63 isoforms exhibited a longer half-life than TAp63 isoforms and deletion of the TA domain reduced the degradation of TAp63 protein by 26S proteasome pathway. [43, 54] The FWL motif, that was reported to be essential for p53 degradation, also promoted mdm2-mediated TAp63 degradation. [55] [56] [57] [58] Other study showed that TAp63α isoform exhibited a longer half-life than TAp63γ isoform, and the C-terminal end appeared to play a role in their stability. [58] The C-terminal SAM domain in the α isoform was reported to protect p63 through FWL motif-mediated degradation. [35, 59] The degradation of ΔNp63 was also reported to process through proteosome-dependent pathway and stratifyin (14-3-3σ) and RACK1 were believed to be involved. [60] Cellular protein species that have been reported to interact with TAp63 to stimulate TAp63 activity include ASPP1, [61] ASPP2, [61] PML, [62] Sp1, [63] SSRP1 and p300. [64, 65] These studies suggested that all p53 family members share common coactivators. Intriguingly, p14ARF was reported to activate and stabilize p53, but inhibited p63. [66] p63 activity was also regulated by post-translational modifications. Under genotoxic stresses, some Ser/Thr residues of TAp63α and γ have been shown to be dephosphorylated leading to protein stabilization. [54] However, in Saos2 osteosarcoma cells, genotoxic stresses was shown to promote the degradation of ΔNp63α. [67] In addition, the SUMOylation of the ΔNp63α at a single lysine reside, k637, was reported to promote the proteasome-dependent degradation. [68] The aforementioned studies suggested multiple mechanisms are involved in the regulation of p63 stability.
p63 in cancers
Functional studies of p63 and p53 showed a close relation between developmental processes and tumorigenesis. [69] There have been numerous studies shown that p63 plays critical roles in cell cycle arrest, DNA damage repair process and apoptosis; however, its precise role in cancer remained unclear. Yang et al., (1998) were the first to show that ΔNp63α is the primary p63 variant expressed in squamous epithelial tissues. [2] Overexpression of p63 has been found to be a frequent event in some human cancers, including 93% of squamous cell carcinomas of the lung, 10% of ductal carcinomas of the breast and 25% of endometrioid carcinomas of the ovary. [70] On the other hand, p63 was rarely detected in cancers developed from tissues that do not normally express p63, including breast and lung adenocarcinomas, possibly due to the lack in these tumors of the epithelial basal cells where p63 is normally expressed. [40, 70] In addition, a recent report indicated that p63 plays important roles in the development and progression of grade I/II endometrial adenocarcinoma. [71] It has been suggested that dysregulated expression of p63 is often correlated with amplification of its genomic locus, 3q27-28 and is frequently occurred in human epithelial cancers. [40] Studies on a cohort of 245 esophageal tumors showed that both TAp63 and ΔNp63 isoforms were upregulated at the transcriptional level in squamous cell carcinoma. [72] ΔNp63α was identified to be expressed in squamous epithelial tissues and was believed to antagonize the tumor suppressor function of p53. [2] Although TAp63 is functionally and structurally similar to the tumor suppressor p53, the functional role of its expression in this context has not been fully demonstrated. Numerous recent studies have suggested that TAp63 exerted different effects in carcinogenesis. For instances, loss of p63 expression was associated with poor prognosis of the bladder carcinoma [73] and was shown to increase cell migration and expression of genes involved in tumor invasion and metastasis. [74] Another study showed that the expression of p63 was required for p53 expressing cells to undergo apoptosis in response to DNA damage. [36] Most recently, p63 and p53 were found to repress carcinogenesis through repressing telomerase expression. [75] In addition, TAp63 was reported to trigger cell senescence and halt tumorigenesis irrespective of p53 expression status. [76] Ectopic expression of ΔNp63α was reported to increase the half-life of the hypoxia inducible factor 1α (HIF-1α), [77] leading to upregulation of the vascular endothelial growth factor (VEGF) due to elevated binding of HIF-1α to the VEGF promoter. [77] ΔNp63α was also reported to interact with the B56α regulatory subunit of the protein phosphatase 2A and glycogen synthase kinase 3b proteins [78, 79] that were suggested to inhibit the destruction complex of adenomatous polyposis coli. [78, 79] Inhibition of the destruction complex downregulated phosphorylated b-catenin leading to transcriptional activation of matrix metalloproteinases. [78, 79] We recently found that the proliferation of NPC-076 cells was greatly suppressed when ΔNp63 was silenced by specific ΔNp63 siRNA. [80] This study also showed that knockdown of ΔNp63 resulted in the upregulation of CKIs, including p27 and p57 in both mRNA and protein levels and increased G1 phase cell and apoptotic cell populations. These findings suggested that ΔNp63 plays important roles in the regulation of NPC-076 cell-cycle progression, and contributes to the maintenance of NPC-076 tumor cell phenotype.
Our previous studies also showed that the transcriptional activity of the TAp63 promoter and TAp63 protein level were both upregulated by an increased c-jun expression in Hep3B human hepatocellular carcinoma cell. [81] The elevated TAp63 expression was coincided with an increased binding of c-jun to the TAp63 promoter. Moreover, knockdown of TAp63 expression by shRNA led to an increased proliferation of Hep3B cell compared to that of the mock cell, suggesting a growth suppressive effect of TAp63 expression. [81] Ectopic expression of p53 in p53-deficient cell (Hep3B) reduced TAp63 promoter activity and knockdown of TAp63 attenuated doxorubicin-induced cell growth arrest by promoting cell cycle progression via increasing the percentage of G2/M cells. [82] Moreover, knockdown of TAp63 increased cell sensitivity to doxorubicin-induced genomic damage. Our results suggested that TAp63 may play a compensatory role in p53-deficient cancer cells in cell cycle regulation and DNA damage repair. [82] Collectively, these studies suggested a tumor suppressor function for TAp63. However, in other studies, TAp63 was found to function as a proto-oncogene when it was improperly reactivated. [83] Yen et al., showed that the expression of TAp63 in esophageal carcinoma was upregulated during early carcinogenesis and downregulated as the tumor progresses. [84] Despite the above mentioned studies, the exact roles of p63 in tumorigenesis have been unclear.
Conclusions
High levels of p63 expression were found in the basal cells of many stratified epithelial tissues where a majority of human neoplasm develops. It is therefore suggested that p63 not only is essential for epithelial development, it may also be involved in pathological conditions, including cancer development and DNA damage repair. The balance between TAp63 and ΔNp63 isoforms appears to be important in regulating cellular fates, such as maintenance of uncommitted stem cell vs. differentiation, survival vs. apoptosis, and tumorigenesis vs. tumor suppression. We suggest that understanding the roles of interplays between TAp63 and ΔNp63 could probably provide useful information in ocular surface reconstruction of the limbal deficient eyes, normal epithelial development, carcinogenesis and the protective effect of p53 deficient cells under genotoxicity.
